The Zest™ Petite Nasal Mask is intended to be used by individuals greater than 66lbs (30kg) who have been diagnosed by a physician as requiring CPAP or Bi-Level Ventilator treatment. The Zest™ Petite Nasal Mask is intended for Single Patient Use in the home and Multiple Patient Use in the hospital or other clinical setting where proper disinfection of the device can occur between patient uses.
Device Story
Zest™ Petite Nasal Mask is a non-invasive respiratory interface; delivers pressurized gases from CPAP or Bi-Level ventilator systems to patient. Device consists of silicone seal positioned over nose and upper lip; secured via headgear straps; connects to breathing tube via swivel adaptor. Integrated exhalation vents (bias holes) flush exhaled gases to room air. Used in home or clinical settings; operated by patient or healthcare provider. Smaller dimensions and seal size compared to predicate Zest Nasal Mask to accommodate patients with smaller facial features. Facilitates effective ventilation therapy; improves patient comfort through contoured seal design.
Clinical Evidence
Bench testing only. Performance and biocompatibility testing compared to predicate Zest Nasal Mask (K083832) and HC432 Full Face Mask (K061236) demonstrate substantial equivalence.
Technological Characteristics
Non-invasive nasal mask; silicone seal; headgear straps; swivel adaptor; integrated exhalation vents. Dimensions and seal contoured for smaller facial profiles. Biocompatible materials. Non-powered, passive device.
Indications for Use
Indicated for patients >66lbs (30kg) requiring CPAP or Bi-Level ventilator treatment. Suitable for home (single-patient) or clinical (multi-patient) use.
Regulatory Classification
Identification
A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.
{0}------------------------------------------------
# SECTION 5 - 510K Summary
MAR 2 4 2011
K103786 aykel sherです HEALTHCARE
15 Maurice Paykel Place, East Tamaki P O Box 14 348, Panmure Auckland, New Zealand Telephone: +64 9 574 0100 Facsimile: +64 9 574 0148 Website: www.fphcare.com
| Contact person | Tina Mason |
|------------------------|---------------------------------------------------------------------------------------------------------------|
| Date Prepared | 14th December 2010 |
| Trade Name | Zest™ Petite Nasal Mask |
| Common Name | Nasal Mask |
| Classification<br>Name | Non continuous ventilator IPPB<br>(21 CFR § 868.5905, product code BZD) |
| Predicate<br>Devices | K083832 Fisher & Paykel Healthcare Zest Nasal Mask |
| | K092835 Respironics ComfortGel Blue Nasal Mask |
| | K061236 Fisher & Paykel Healthcare Flexifit HC432 Full Face<br>Mask (predicate for material biocompatibility) |
{1}------------------------------------------------
## 5.1 Description
The Zest™ Petite Nasal Mask is a respiratory mask which is non invasive, the Silicone Seal is positioned over the nose, and it seals on the area around the nose, and the upper lip. The mask is held on the face with headgear straps. It connects to a single breathing tube via a swivel adaptor, to receive pressurized gases. On the mask base are exhalation vents (bias holes) that allow exhaled gases to be continually flushed and removed to room air. The silicone seal is contoured for comfort and to reduce leakage.
## 5.2 Intended Use
The Zest™ Petite Nasal Mask is intended to be used by individuals greater than 66lbs (30kg) who have been diagnosed by a physician as requiring CPAP or Bi-Level Ventilator treatment. The Zest™ Petite Nasal Mask is intended for Single Patient Use in the home and Multiple Patient Use in the hospital or other clinical setting where proper disinfection of the device can occur between patient uses.
## 5.3 Technological Characteristics Comparison
The Zest™ Petite Nasal Mask is very similar to the predicate Fisher & Paykel Healthcare Zest™ Nasal Mask. Both masks are for non continuous ventilation, and deliver CPAP gasses through the nose. The main difference is that the Zest Petite Nasal Mask is a smaller size than the Zest Nasal Mask. The overall dimensions of the Zest Petite Nasal Mask are smaller and the silicone seal is smaller. All the technology, features and specifications are identical. The only difference is that it will fit patients with smaller faces.
## 5.4 Non-clinical Tests
Testing of the Zest™ Petite Nasal Mask was compared to the predicate Fisher & Paykel Healthcare Zest™ Nasal Mask for performance and for biocompatibility. These tests demonstrate substantial equivalence of the Zest™ Petite Nasal Mask to the predicate mask. Copies of test reports are included in Appendix B.
## 5.5 Conclusion
The comparison of features, performance, and biocompatibility are identical the predicate Fisher & Paykel Healthcare Zest™ Nasal Mask (K083832) and the HC432 Full Face Mask (K061236) for biocompatibility.
The comparison of intended use 661bs (30kg) is identical to the predicate Respironics ComfortGel Blue Nasal Mask (K092835) and is identical to the Fisher & Paykel Healthcare Zest™ Nasal Mask (K083832) in terms of Single Patient Use in the home and Multiple Patient Use in the hospital or other clinical setting.
The Zest™ Petite Nasal Mask is proven to be safe and effective for CPAP and Bilevel ventilation therapy.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features the department's name encircling a symbol. The symbol consists of a stylized caduceus, a traditional symbol of medicine, with three wavy lines representing the three branches of government.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Ms. Tina Mason Regulatory Affairs Engineer Fisher & Paykel Healthcare, Limited 15 Maurice Paykel Place East Tamaki, Auckland NEW ZEALAND 2013
MAR 2 4 2011
Re: K103786
Trade/Device Name: Zest™ Petite Nasal Mask Regulation Number: 21 CFR 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: II Product Code: BZD Dated: December 20, 2010 Received: December 27, 2010
Dear Ms. Mason:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practive, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH docs not evaluate information related to contract liability warranties. We remind you, forvever, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
#### Page 2 - Ms. Mason
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal regulering. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 53) -542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
hh for
Anthony Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
#### Enclosure
{4}------------------------------------------------
# SECTION 4 - Indications for Use Statement
510(k) Number
Device Name Zest™ Petite Nasal Mask
Indications for Use:
The Zest™ Petite Nasal Mask is intended to be used by individuals greater than 66lbs (30kg) who have been diagnosed by a physician as requiring CPAP or Bi-Level Ventilator treatment. The Zest™ Petite Nasal Mask is intended for Single Patient Use in the home and Multiple Patient Use in the hospital or other clinical setting where proper disinfection of the device can occur between patient uses.
Prescription Use > (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
Concurrence of CDRH, Office of Device Evaluation (ODE)
L. Schulltho
(Division Sign-Off)
Division of Anesthesiology, General Hospital
Infection Control and Dental Devices
§10(k) Number: 4103786
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.